Skip to content

Clinical trials

Terminated Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Terminated Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20062
20101
20121
20142
20161
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ariad Pharmaceuticals1
Bristol-Myers Squibb1
European Society for Blood and Marrow Transplantation1
Incyte Corporation1
Institut Bergonié1
Pfizer1
Poitiers University Hospital1
Sun Pharma Advanced Research Company Limited1
Teva Branded Pharmaceutical Products R&D, Inc.1
University Hospital, Angers1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive10
Leukemia2
Anemia, Refractory, with Excess of Blasts1
Bone Marrow Diseases1
Bronchiolitis Obliterans Syndrome1
Graft vs Host Disease1
Hematologic Diseases1
Hematologic Neoplasms1
Hodgkin Disease1
Immune System Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.